Fascin-expressing dendritic cells dominate in polymyositis and dermatomyositis

Journal of Rheumatology

Volumn 40, Issue 2, 2013, Pages 186-191

  Gendek Kubiak, Hanna ^a   Gendek, Ewa G ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Dendritic cell; Fascin; Immunohistochemistry; Langerin; Myositis

Indexed keywords

FASCIN; LANGERIN;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DERMATOMYOSITIS; ENDOMYSIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; PERIMYSIUM; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD; CARRIER PROTEINS; CASE-CONTROL STUDIES; DENDRITIC CELLS; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MALE; MANNOSE-BINDING LECTINS; MICROFILAMENT PROTEINS; MIDDLE AGED; POLYMYOSITIS;

EID: 84873597421     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120590     Document Type: Article

References (36)

1. De Bleecker JL, Engel AG. Immunocytochemical study of CD45 T-cell isoforms in inflammatory myopathies. Am J Pathol 1995;14:1178-87.
2. Arahata K, Engel AG. Monoclonal-antibody analysis of mononuclear-cells in myopathies. 1. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle-fibers invaded by T-cells. Ann Neurol 1984;16:193-208.
3. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis - A quantitative study. Ann Neurol 1990;27:343-56.
4. Gendek-Kubiak H, Gendek EG. Immunolocalization of protectin (CD59) and macrophages in polymyositis and dermatomyositis. J Neuroimmunol 2004;149:187-94.
5. Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005;57:664-78.
6. Page G, Chevrel G, Miossec P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis - Interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum 2004;50:199-208.
7. Chevrel G, Page G, Miossec P. Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis. Autoimmunity 2006;39:171-6.
8. Greenberg SA. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 2007;69:2008-19.
9. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007;7:19-30.
10. Chikwava K, Jaffe R. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatr Dev Pathol 2004;7:607-14.
11. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol 2002;23:445-9.
12. Novak N, Koch S, Allam JP, Bieber T. Dendritic cells: Bridging innate and adaptive immunity in atopic dermatitis. J Allergy Clin Immunol 2010;125:50-9.
13. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008;29:21-32.
14. Peter ME. ROS eliminate danger. Immunity 2008;29:1-2.
15. Berger TG, Schulze-Koops H, Schafer M, Muller E, Lutz MB. Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro. PLoS One 2009;4:e6645.
16. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002;2:151-61.
17. Chen YW, Shi R, Geraci N, Shrestha S, Gordish-Dressman H, Pachman LM. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC Immunol 2008;9:43.
18. Ross R, Jonuleit H, Bros M, Ross XL, Yamashiro S, Matsumura F, et al. Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J Invest Dermatol 2000;115:658-63.
19. + human pulmonary cells. Respir Med 2009;103:935-8.
20. Zuniga EI, McGavern DB, Pruneda-Paz JL, Teng C, Oldstone MB. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 2004;5:1227-34.
21. Abdullah HM, Higuchi I, Kubota R, Matsuura E, Hashiguchi A, Abdelbary NH, et al. Histopathological differences between human T-lymphotropic virus type 1-positive and human T-lymphotropic virus type 1-negative polymyositis. Clin Exp Neuroimmunol 2011;2:12-24.
22. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000;12:71-81.
23. Dziegiel P, Dolinska-Krajewska B, Dumanska M, Weclawek J, Jelen M, Podhorska-Okolow M, et al. Coexpression of CD1a, langerin and Birbeck's granules in Langerhans cell histiocytoses (LCH) in children: Ultrastructural and immunocytochemical studies. Folia Histochem Cytobiol 2007;45:21-5.
24. Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, Rea TH, et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 2004; 113:701-8.
25. Valladeau J, Clair-Moninot V, Dezutter-Dambuyant C, Pin JJ, Kissenpfennig A, Mattei MG, et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 2002;168:782-92.
26. Al-Alwan MM, Rowden G, Lee TDG, West KA. Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol 2001;166:338-45.
27. Gendek-Kubiak H, Gendek EG. Dendritic cells' markers in idiopathic inflammatory myopathies [abstract]. 8th EFIS-EJI Tatra Immunology Conference, Strbske Pleso, Slovak Republic, 2008; p17.
28. Gendek-Kubiak H, Gendek EG. Some equivocality of "markers" used for identification of infiltration cells in myositic muscles [abstract]. Folia Histochem Cytobiol 2008;46 Suppl:S60.
29. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
30. Zar JH. Two sample hypotheses. In: McElroy WD, Swanson CP, editors. Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall Inc.; 1974:101-20.
31. Tournadre A, Porcherot M, Cherin P, Marie I, Hachulla E, Miossec P. Th1 and Th17 balance in inflammatory myopathies: Interaction with dendritic cells and possible link with response to high-dose immunoglobulins. Cytokine 2009;46:297-301.
32. Greenberg SA, Pinkus GS, Amato AA, Pinkus JL. Myeloid dendritic cells in inclusion-body myositis and polymyositis. Muscle Nerve 2007;35:17-23.
33. Reed AM, Ernste F. The inflammatory milieu in idiopathic inflammatory myositis. Curr Rheumatol Rep 2009;11:295-301.
34. Hussein MRA, Abu-Dief EE, Kamel NF, Mostafa MG. Steroid therapy is associated with decreased numbers of dendritic cells and fibroblasts, and increased numbers of satellite cells, in the dystrophic skeletal muscle. J Clin Pathol 2010;63:805-13.
35. Hussein MR, Hamed SA, Mostafa MG, Abu-Dief EE, Kamel NF, Kandil MR. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies. Int J Exp Pathol 2006;87:451-61.
36. Chen YW, Zhao P, Borup R, Hoffman EP. Expression profiling in the muscular dystrophies. J Cell Biol 2000;151:1321-36.